Signalife names Ehrlichman to board, operations director

Signalife has appointed Lee B. Ehrlichman to the company's board of directors and as its director of operations.

Ehrlichman, who oversaw outpatient real-time cardiac telemetry technology and call center monitoring as CEO and president of Cardiac Telecom, will oversee company operations as Signalife’s operations director, a consulting position. In the position, he will monitor all production activities and allow timely deliveries of product, overseeing regulatory activities, as well as research and development actions, the Greenville, S.C.-based company said.

As operations director, Ehrlichman is expected to operate out of the company’s Los Angeles offices and laboratory facilities on a full-time basis, Signalife said. The company also said that Ehrlichman will take a lead role in company sales, both in the remote cardiac monitoring market as well as traditional ECG markets.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.